Aripiprazole in autism spectrum disorders and fragile X syndrome.
about
Aripiprazole for autism spectrum disorders (ASD)Aripiprazole for autism spectrum disorders (ASD)Aggression in autism spectrum disorder: presentation and treatment optionsAripiprazole for treating irritability in children & adolescents with autism: A systematic reviewFragile X syndrome and targeted treatment trials.Unstable mutations in the FMR1 gene and the phenotypesReward processing in autism: a thematic series.Potential therapeutic interventions for fragile X syndromeThe psychiatric presentation of fragile x: evolution of the diagnosis and treatment of the psychiatric comorbidities of fragile X syndrome.A fourth case of Feingold syndrome type 2: psychiatric presentation and management.Targeted treatments for fragile X syndrome.A 'learning platform' approach to outcome measurement in fragile X syndrome: a preliminary psychometric study.Aripiprazole for the treatment of irritability associated with autism.Review of the pharmacotherapy of irritability of autism.Plasticity and mTOR: towards restoration of impaired synaptic plasticity in mTOR-related neurogenetic disordersAtypical antipsychotics in the treatment of children and adolescents with pervasive developmental disorders.Autism Spectrum Disorder in Fragile X Syndrome: Cooccurring Conditions and Current Treatment.Lurasidone for the treatment of irritability and anger in autism spectrum disorders.Pharmacotherapy for Fragile X Syndrome: Progress to Date.Second generation antipsychotics in 'real-life' paediatric patients. Adverse drug reactions and clinical outcomes of drug switch.Neurite outgrowth mediated by the heat shock protein Hsp90α: a novel target for the antipsychotic drug aripiprazole.A prospective open-label study of aripiprazole in fragile X syndrome.Fragile X syndromeReward circuitry dysfunction in psychiatric and neurodevelopmental disorders and genetic syndromes: animal models and clinical findings
P2860
Q24197830-EF7FBA2B-F9BC-4577-A7D6-EC0E56433B74Q26471439-8C30F3E3-00D8-4AF6-8F25-8E4FDFD76087Q26744346-FA578B61-A1CC-4028-9386-914781826D29Q26784199-EEDFF635-C5A4-4568-B914-4206462E438AQ26865162-76E0F465-6181-4BE2-99CC-992DB5F40EACQ26996649-790BD557-568A-4A36-A8FF-61CEE9C4DEC2Q30462673-4F83C435-0CEB-4B7A-A461-7DB1DA6D4E82Q30473378-2B7BC59F-9612-4E00-ACEE-28D590081CFAQ34213731-DB9C40BC-07CA-4392-A6F0-3CAFF32604E6Q34573267-6E355E78-AE95-4999-A4B4-47C6589F5712Q35680726-7504E185-3457-45B8-8C3E-58E5DC0A1F97Q36157807-962DCA0A-08DD-40ED-96FE-C234E9EE40AFQ37835845-2B26EF47-C651-41F1-B43B-C8360CA15702Q38006705-D89C8B52-349C-49F6-A971-8A2D4BDF921EQ38012453-0D2F4959-406B-440F-A2C0-80552F7C7217Q38095762-2F5AC9E4-94DE-46B3-A90E-23BA73371562Q38621496-93EE706C-9F75-4F60-9788-C1822A2CC478Q38689883-FB1DE947-CD9B-4FEA-B6AB-949732A08AFFQ38726962-45068EDF-E664-4D31-B984-F21D1262EE7DQ39162868-0364AAEC-3816-4ED0-BF20-9F8E2428CC28Q41828115-24CF782A-0A42-4926-A9D9-D6D4F7904574Q47293259-6CFBC8AA-0494-41A7-8855-01DEF957D08BQ57828399-2D6CA8C5-D2BF-4D3B-944F-69D1989B2156Q59292055-E7E5AA03-5EC8-41DC-A38B-5B7B407838BC
P2860
Aripiprazole in autism spectrum disorders and fragile X syndrome.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Aripiprazole in autism spectrum disorders and fragile X syndrome.
@ast
Aripiprazole in autism spectrum disorders and fragile X syndrome.
@en
Aripiprazole in autism spectrum disorders and fragile X syndrome.
@nl
type
label
Aripiprazole in autism spectrum disorders and fragile X syndrome.
@ast
Aripiprazole in autism spectrum disorders and fragile X syndrome.
@en
Aripiprazole in autism spectrum disorders and fragile X syndrome.
@nl
prefLabel
Aripiprazole in autism spectrum disorders and fragile X syndrome.
@ast
Aripiprazole in autism spectrum disorders and fragile X syndrome.
@en
Aripiprazole in autism spectrum disorders and fragile X syndrome.
@nl
P2093
P2860
P1433
P1476
Aripiprazole in autism spectrum disorders and fragile X syndrome.
@en
P2093
Craig A Erickson
David J Posey
Kimberly A Stigler
P2860
P2888
P304
P356
10.1016/J.NURT.2010.04.001
P577
2010-07-01T00:00:00Z
P5875
P6179
1040149961